» Articles » PMID: 36421722

The Role of Macrophage Iron Overload and Ferroptosis in Atherosclerosis

Overview
Journal Biomolecules
Publisher MDPI
Date 2022 Nov 24
PMID 36421722
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis is a new type of cell death caused by iron-dependent lipid peroxidation. In recent years, it has been found that ferroptosis can promote the progression of atherosclerosis (AS). Macrophages have been proven to play multiple roles in the occurrence and development of AS. Iron is a necessary mineral that participates in different functions of macrophages under physiological conditions. But iron overload and ferroptosis in macrophages may promote the progression of AS. Herein, we summarize the role of iron overload and ferroptosis in macrophages in AS from the perspective of iron metabolism, and iron overload and ferroptosis are significant contributors to AS development.

Citing Articles

Major heme proteins hemoglobin and myoglobin with respect to their roles in oxidative stress - a brief review.

Sil R, Chakraborti A Front Chem. 2025; 13:1543455.

PMID: 40070406 PMC: 11893434. DOI: 10.3389/fchem.2025.1543455.


Ferroptosis, pathogenesis and therapy in AS co-depression disease.

Zhao Y, Ren P, Luo Q, Li X, Cheng X, Wen Y Front Pharmacol. 2025; 16:1516601.

PMID: 40066336 PMC: 11891183. DOI: 10.3389/fphar.2025.1516601.


Application of Nanomaterials in Early Imaging and Advanced Treatment of Atherosclerosis.

Zhou Q, Wang Y, Si G, Chen X, Mu D, Zhang B Chem Biomed Imaging. 2025; 3(2):51-76.

PMID: 40018650 PMC: 11863161. DOI: 10.1021/cbmi.4c00064.


Intracellular iron accumulation throughout the progression of sepsis influences the phenotype and function of activated macrophages in renal tissue damage.

Hanna M, Akabawy A, Khalifa M, Elbaset M, Imam R, Seddiek H Front Physiol. 2025; 16:1430946.

PMID: 39949667 PMC: 11821637. DOI: 10.3389/fphys.2025.1430946.


Deciphering Oxidative Stress in Cardiovascular Disease Progression: A Blueprint for Mechanistic Understanding and Therapeutic Innovation.

Zhang Z, Guo J Antioxidants (Basel). 2025; 14(1).

PMID: 39857372 PMC: 11759168. DOI: 10.3390/antiox14010038.


References
1.
Chen Q, Lv J, Yang W, Xu B, Wang Z, Yu Z . Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis. Theranostics. 2019; 9(22):6424-6442. PMC: 6771242. DOI: 10.7150/thno.35528. View

2.
Haschka D, Hoffmann A, Weiss G . Iron in immune cell function and host defense. Semin Cell Dev Biol. 2021; 115:27-36. DOI: 10.1016/j.semcdb.2020.12.005. View

3.
Bersuker K, Hendricks J, Li Z, Magtanong L, Ford B, Tang P . The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019; 575(7784):688-692. PMC: 6883167. DOI: 10.1038/s41586-019-1705-2. View

4.
Chawla A, Boisvert W, Lee C, Laffitte B, Barak Y, Joseph S . A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell. 2001; 7(1):161-71. DOI: 10.1016/s1097-2765(01)00164-2. View

5.
Ito F, Sono Y, Ito T . Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation. Antioxidants (Basel). 2019; 8(3). PMC: 6466575. DOI: 10.3390/antiox8030072. View